Literature DB >> 21475530

Prevalence of metabolic syndrome among qassim university personnel in saudi arabia.

Issam E Barrimah1, Abdul Rahman Mohaimeed, Farid Midhat, Hani A Al-Shobili.   

Abstract

OBJECTIVE: to estimate the prevalence of metabolic syndrome among Qassim university personnel in Saudi Arabia using the definition proposed by NCEP ATPIII.
METHODS: a cross sectional study that included all male university staff of different ages and careers. 560 individuals participated in this study with a response rate of 85%. For all participants, the data collected were sociodemographic characteristics, past history or receiving medication for diabetes or hypertension, smoking habits, physical activity, and measurements necessary to identify metabolic syndrome.
RESULTS: Prevalence of metabolic syndrome was 31.4%. The prevalence was found to show a steady increase with increasing age, BMI and serum cholesterol. General obesity measured by BMI was the most common component associated with the syndrome where 75% of participants suffered from overweight and obesity. Participants with high-density lipoprotein below protective level constituted 73.6%, while those with total cholesterol and triglyceride above clinically normal level constituted 60.0% & 46.4% respectively. Elevated fasting plasma glucose and hypertension were the least common. After adjustment, factors found to be associated with metabolic syndrome were being a Saudi national, smoking, not doing regular exercise, being obese having total serum cholesterol above 180 mg/dl, and age groups above 40 years.
CONCLUSION: Almost a third of the university personnel have metabolic syndrome and therefore they are at higher risk for both cardiovascular diseases and diabetes mellitus. Similar studies are required among a wider range of subjects to assess the scope of the problem in Saudi Arabia.

Entities:  

Year:  2009        PMID: 21475530      PMCID: PMC3068818     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  17 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Prevalence of metabolic syndrome in Saudi adult soldiers.

Authors:  Dhafer A Al-Qahtani; Mohammed L Imtiaz
Journal:  Saudi Med J       Date:  2005-09       Impact factor: 1.484

3.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

4.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

5.  The metabolic syndrome in the West Bank population: an urban-rural comparison.

Authors:  H F Abdul-Rahim; A Husseini; E Bjertness; R Giacaman; N H Gordon; J Jervell
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

6.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

Review 7.  Diagnosis, prevention, and intervention for the metabolic syndrome.

Authors:  Cranford L Scott
Journal:  Am J Cardiol       Date:  2003-07-03       Impact factor: 2.778

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Prevalence of the metabolic syndrome in middle-aged men and women.

Authors:  Raquel Villegas; Ivan J Perry; Don Creagh; Rita Hinchion; Domhnall O'Halloran
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

10.  The prevalence of the metabolic syndrome among arab americans.

Authors:  Linda A Jaber; Morton B Brown; Adnan Hammad; Qian Zhu; William H Herman
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

View more
  6 in total

1.  The importance of local criteria in the diagnosis of metabolic syndrome in Saudi Arabia.

Authors:  Suhad M Bahijri; Rajaa M Al Raddadi
Journal:  Ther Adv Endocrinol Metab       Date:  2013-04       Impact factor: 3.565

2.  Metabolic syndrome: Risk factors among adults in Kingdom of Saudi Arabia.

Authors:  Naji J Aljohani
Journal:  J Family Community Med       Date:  2014-09

3.  Risk profile of coronary heart disease among the staff members of Qassim University, Saudi Arabia.

Authors:  Sultan A L Nohair; Abdulrahman A L Mohaimeed; Fawzy Sharaf; Zahid Naeem; Farid Midhet; Homaidan A L Homaidan; Sandra J Winter
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jan-Mar

4.  Gender-dependent associations between socioeconomic status and metabolic syndrome: a cross-sectional study in the adult Saudi population.

Authors:  Nasser M Al-Daghri; Khalid M Alkharfy; Omar S Al-Attas; Nasiruddin Khan; Hanan A Alfawaz; Saad A Alghanim; Mansour A Al-Yousef; Abdulrahman S M Al-Ajlan; Majed S Alokail
Journal:  BMC Cardiovasc Disord       Date:  2014-04-14       Impact factor: 2.298

5.  Selected dietary nutrients and the prevalence of metabolic syndrome in adult males and females in Saudi Arabia: a pilot study.

Authors:  Nasser M Al-Daghri; Nasiruddin Khan; Khalid M Alkharfy; Omar S Al-Attas; Majed S Alokail; Hanan A Alfawaz; Abdulaziz Alothman; Paul M Vanhoutte
Journal:  Nutrients       Date:  2013-11-19       Impact factor: 5.717

6.  Prevalence of obesity in Hail region, KSA: in a comprehensive survey.

Authors:  Hussain Gadelkarim Ahmed; Ibrahim Abdelmajeed Ginawi; Abdelbaset Mohamed Elasbali; Ibraheem M Ashankyty; Awdah M Al-Hazimi
Journal:  J Obes       Date:  2014-06-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.